Hydrochloric Acid → (R)-2-Ethyl-piperazine-1-carboxylic acid 2,6-difluoro-3-methoxy-benzyl ester hydrochloride
反応式
[H-].[Na+].[F:3][C:4]1[C:28]([OH:29])=[CH:27][CH:26]=[C:25]([F:30])[C:5]=1[CH2:6][O:7][C:8]([N:10]1[CH2:15][CH2:14][N:13](C(OC(C)(C)C)=O)[CH2:12][C@H:11]1[CH2:23][CH3:24])=[O:9].[CH3:31]I.[ClH:33]>CN(C=O)C>[ClH:33].[F:3][C:4]1[C:28]([O:29][CH3:31])=[CH:27][CH:26]=[C:25]([F:30])[C:5]=1[CH2:6][O:7][C:8]([N:10]1[CH2:15][CH2:14][NH:13][CH2:12][C@H:11]1[CH2:23][CH3:24])=[O:9]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
A mixture of 5.03 mg (0.126 mmol) NaH (60% suspension in mineral oil) and 33.6 mg (0.084 mmol) (R)-2-Ethyl-piperazine-1,4-dicarboxylic acid 4-tert-butyl ester 1-(2,6-difluoro-3-hydroxy-benzyl) ester in 1 ml DMF was stirred for 30 min at room temperature under argon. 13.1 mg (0.092 mmol) methyliodide was added and the mixture was stirred 30 min at room temperature. After addition of 0.06 ml HCl (37%) the mixture was purified with preparative HPLC eluting with an acetonitrile/water gradient. The fractions containing the desired intermediate were combined and evaporated to dryness. The residue was taken up in 1 ml dioxane and 0.125 ml HCl (37%) and stirred for 30 min at 60° C. Evaporation of the mixture yielded 22 mg (75%) of the title compound. MS (ISP): 315 (M+H)+.
後処理
- stirringthe mixture was stirred 30 min at room temperature
- customwas purified with preparative HPLC
- washeluting with an acetonitrile/water gradient
- additionThe fractions containing the desired intermediate
- customevaporated to dryness
- stirring0.125 ml HCl (37%) and stirred for 30 min at 60° C
- customEvaporation of the mixture
出典と根拠
- ORDレコード
- ord-2526b19ad8104a7b9a42ba46e9a693c7
- 出典データセット
- uspto-grants-2006_04
- 特許番号
- US07022707B2
反応ノート
読み込み中…